Cambridge Innovation Capital appoints Sir Nigel Wilson as Chair

Former Rolls-Royce CFO Panos Kakoullis also appointed as a Non-Executive Director.

Cambridge Innovation Capital commits £100m to back University of Cambridge spinouts

New Entrepreneur in Residence programme matches serial entrepreneurs with academics to develop world-leading ideas and IP.

CMR Surgical raises more than $200m to accelerate growth in US and globally

Global surgical robotics company CMR Surgical in Cambridge has closed a funding round of more than $200 million to underpin worldwide expansion – notably in the US.

The haul has been raised through a combination of equity and debt capital to support the company’s ambitious growth plans.

Cambridge Innovation Capital co-leads $31M seed financing for TRIMTECH Therapeutics to advance neurodegenerative disease treatments

Cambridge Innovation Capital (CIC), a leading investor in life sciences and deep tech companies, today announces its role as a co-lead investor in TRIMTECH Therapeutics’ $31 million (£25 million) seed funding round.

British Patient Capital announces £20m commitment to Cambridge Innovation Capital £100m Opportunity Fund

British Patient Capital, a commercial subsidiary of the British Business Bank, has made a £20 million cornerstone commitment to Cambridge Innovation Capital’s (CIC) £100 million Opportunity Fund, alongside Aviva Investors.

New £100m Cambridge Innovation Capital fund launched

Cambridge Innovation Capital has launched a new £100 million Opportunity Fund – anchored by Aviva Investors and British Patient Capital – to invest in growing DeepTech and life science companies.

Epitopea announces license and research collaboration agreement with MSD to identify cryptigenTM tumor-specific antigens

Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, announces a license and research collaboration agreement with MSD (tradename of Merck & Co.

Cambridge GaN Devices secures $32M to drive growth in power semiconductor industry

Cambridge GaN Devices (CGD), a leading innovator in gallium nitride (GaN) power devices, has successfully closed a $32 million Series C funding round.

Salience Labs closed Series A round led by Applied Ventures and ICM HPQC Fund

Salience Labs Limited, a leader in photonic solutions targeting connectivity for AI datacenter infrastructure, today announced the successful close of $30 million in Series A financing led by ICM HPQC Fund and App

An open letter to the Government underscoring the critical role Greater Cambridge can play in the UK’s sustainable and inclusive national renewal

If science were a country then Cambridge would likely be its capital, and if discovery were a global competition the city and region would regularly be winning for Britain. That’s because Greater Cambridge is where innovation makes history and where the future comes first.

Cambridge Innovation Capital (CIC) invests in Forefront RF

Cambridge Innovation Capital (CIC), a leading venture capital firm embedded in the Cambridge UK ecosystem, is pleased to announce its investment in Forefront RF, with the completion of a £16 million Series A financing round.

Pragmatic Semiconductor secures £182m ($231m) investment led by M&G and UK Infrastructure Bank

Largest ever European semiconductor venture funding round supports further expansion of manufacturing in the UK.

Cambridge Innovation Capital invests in Complement Therapeutics’ €72 Million Series A Funding

Cambridge Innovation Capital (CIC), the venture capital investor focused on deeptech and life sciences businesses in the Cambridge ecosystem, has invested in Complement Therapeutics’ €72 Million Series A funding round led

Cambridge Innovation Capital invests in Mosaic Therapeutics $28m Series A Funding

Cambridge Innovation Capital (CIC), the venture capital investor focused on deeptech and life sciences businesses in the Cambridge ecosystem, has invested in Mosaic Therapeutics $28m Series A funding round.

Cambridge Innovation Capital raises £225 million ($300 million) for Fund II

Cambridge Innovation Capital (CIC), the venture capital investor focused on building world-leading deeptech and life sciences businesses connected with the Cambridge ecosystem, raises £225 million ($300 million) for its oversubscribed second fund (Fund II).

Cambridge Innovation Capital looks back on 'transformational year'

Cambridge Innovation Capital presents a video which summarises some of its achievements in 2021, which was a "transformational year" for CIC, according to  Managing Partner Andrew Williamson.

CIC participates in Pretzel Therapeutics’ financing round to develop first-in-class treatments for mitochondrial disease

Cambridge Innovation Capital (CIC), the venture capital investor focused on deeptech and life science businesses in the Cambridge ecosystem, is pleased to announce its participation in the financing raised by Pretzel Therapeutics, to support development of novel therapeutics designed to address currently untreatable conditions.

Origami raises £20 million in Series C funding round led by Barclays

Cambridge based Origami has raised £20.5m of new funding to help drive its next phase of growth.

New Cambridge accelerator for deeptech startups launches with five machine learning investments

Deeptech Labs (DTL), a new post-seed accelerator aimed at deep technology (deeptech) start-ups, has been founded in Cambridge to bring the benefits of its innovation ecosystem to post-Seed deeptech companies from the UK and Europe. 

Sense raises $50m Series B to accelerate launch of COVID-19 molecular test

Sense Biodetection (Sense), has announced that it has raised a $50m Series B investment to advance commercialisation of its Veros™ COVID-19 product and continue development of a portfolio of instrument-free, rapid molecular tests that enable improved access, outcomes, and value through patient-focused decentralised healthcare.

CIC participates in Gyroscope Therapeutics’ £107.8 million Series C financing

Cambridge Innovation Capital (CIC), the venture capital investor focused on deeptech and life science businesses in the Cambridge ecosystem, is pleased to announce its participation in the £107.8 million ($148 million) Series C financing raised by Gyroscope Therapeutics Limited, a clinical-stage gene therapy company focused on treating diseases of the eye.

How to collaborate with Alibaba: IP, legislation and boosting market penetration

A webinar next month is aimed at small-medium sized enterprises that intend to partner with the BATs (Baidu, Alibaba, and Tencent) or to operate a technology company that services the Chinese market. 

Join CIC for its Deep Tech Series A office hours session

Here is a unique opportunity to get in front of one of the UK’s leading Deep Tech Series A investors and learn from them what a good Series A pitch looks like.

Cambridge Innovation Capital leads £7.1M Series A investment in Seldon

Cambridge Innovation Capital (CIC), the venture capital investor enabling visionaries to build global, category-leading companies in the Cambridge ecosystem, is pleased to announce that it has co-led a £7.1M Series A investment in Seldon, the Open Source DevOps company providing enterprises with the tools to manage, serve and optimise their Machine Learning models at scale, alongside AlbionVC…

Start Codon closes new £15 million venture fund to translate life science innovation into successful companies

Start Codon, a life science and healthcare business accelerator based in Cambridge, UK, today announced that it has closed Start Codon Fund I LP  at £15 million ($20 million USD). The Fund will be used to support Start Codon’s offering to start-ups, which includes a minimum of £250K seed funding, business support services, expert guidance, and access to cutting-edge office and lab facilities.